Skip to main content
Haemato AG logo

Haemato AG — Investor Relations & Filings

Ticker · HAEK ISIN · DE000A289VV1 LEI · 529900Q3CGRYVCW7E340 F Wholesale and retail trade
Open in API
Filings indexed 188 across all filing types
Latest filing 2015-05-22 Board/Management Inform…
Country DE Germany
Listing F HAEK

About Haemato AG

https://haemato.de/en/start.html

Haemato AG is a pharmaceutical company focused on the specialty pharma market, concentrating on treatments for chronic diseases and high-priced therapies. The company's business activities include the development, acquisition, licensing, and distribution of a product portfolio that comprises innovative patent-protected medicines, biosimilars, and generics. The portfolio also extends to narcotics, including cannabis products, as well as over-the-counter (OTC) products and special cosmetics. Haemato AG's primary therapeutic areas of focus are HIV/AIDS, neurology, oncology, rheumatology, and ophthalmology.

Recent filings

Filing Released Lang Actions
Datum:22.05.2015
Board/Management Information Classification · 100% confidence The document is a 'Bericht des Aufsichtsrates' (Supervisory Board Report) for HAEMATO AG for the fiscal year 2013. It details the board's oversight activities, meetings, the review of the annual financial statements (Jahresabschluss), and the dependency report (Abhängigkeitsbericht). In German corporate reporting, the Supervisory Board Report is a mandatory component of the Annual Report (10-K equivalent). Since this is a specific component of the annual reporting package rather than a standalone audit opinion or a management announcement, it is classified under the Annual Report category.
2015-05-22 German
Annual Report 2014
Annual Report Classification · 100% confidence The document is explicitly titled '2014 Annual Report' and contains comprehensive financial statements, a letter to shareholders, a report of the supervisory board, and a consolidated management report. It provides detailed financial data for the fiscal year 2014, meeting the criteria for a full annual report rather than an announcement or summary. FY 2014
2015-04-15 English
Annual Report 2014
Annual Report Classification · 100% confidence The document is explicitly titled '2014 Annual Report' and contains comprehensive financial statements, a letter to shareholders, a report of the supervisory board, and a consolidated management report. It provides detailed financial data for the fiscal year 2014, meeting the criteria for a full annual report rather than an announcement or summary. FY 2014
2015-04-15 German
HAEMATO AG: 2014: Preliminary IFRS results, sales growth of 16 % to EUR 202.67 million, annual net income of EUR 6.98 million; confirmation of dividend policy
Earnings Release Classification · 100% confidence The document is a short news release dated March 13, 2015, announcing the 'Preliminary IFRS results' for the year 2014, including sales figures, net income, and confirmation of the dividend policy. This content aligns perfectly with an initial announcement of periodical financial results, which is the definition of an Earnings Release (ER). It is not a comprehensive report (like 10-K or IR) nor is it a transcript or a presentation. Given its brevity and focus on preliminary figures, ER is the most appropriate classification. FY 2014
2015-03-13 English
HAEMATO AG: 2014: Vorlaufiges IFRS-Ergebnis, Umsatzwachstum 16% auf 202,67 Mio. Euro, Jahresuberschuss 6,98 Mio. Euro; Bestatigung Dividendenpolitik
Notice of Dividend Amount Classification · 99% confidence The document is a 'Corporate News' announcement dated March 13, 2015, detailing the preliminary IFRS results for the full year 2014, including revenue growth (202.67 Mio. Euro) and net income (6.98 Mio. Euro). It also mentions a proposed dividend. This content—the initial release of key annual financial figures—is characteristic of an Earnings Release (ER). Although it covers the full year, it is presented as a preliminary announcement ('Vorläufiges IFRS-Ergebnis') and is very brief, suggesting it is the initial highlight release rather than the comprehensive 10-K filing. The document explicitly states it is a 'Corporate News' and was distributed via DGAP, fitting the pattern of an initial results announcement.
2015-03-13 German
Datum:11.03.2015
Annual Report Classification · 100% confidence The document is a 'Jahresabschluss' (Annual Financial Statement) and 'Lagebericht' (Management Report) for HAEMATO AG for the fiscal year 2013. It contains detailed financial performance data, management analysis of the business environment, and market conditions. As it is a comprehensive annual report covering the full fiscal year, it falls under the 10-K category. FY 2013
2015-03-11 German

Browse filings by year

21 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.